The segmented flavivirus Alongshan virus reduces mitochondrial mass by degrading STAT2 to suppress the innate immune response
Journal of Virology · 31.01.2025 · 99 (1)
DOI: 10.1128/jvi.01301-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 31.01.2025. Verfasst von Yinghua Zhao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of…. Hauptthemen laut MEDLINE: Immunity, Innate, STAT2 Transcription Factor, Mitochondria, Flavivirus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Medical Innovaton Team Project of Jilin University, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (SKL-DTID).
Abstract (Originalsprache)
Alongshan virus (ALSV) is a newly discovered pathogen in the Flaviviridae family, characterized by a unique multi-segmented genome that is distantly related to the canonical flaviviruses. Understanding the pathogenic mechanism of this emerging segmented flavivirus is crucial for the development of effective intervention strategies. In this study, we demonstrate that ALSV can infect various mammalian cells and induce the expression of antiviral genes. Furthermore, ALSV is sensitive to IFN-β, but it has developed strategies to counteract the host’s type I IFN response. Mechanistically, ALSV’s nonstructural protein NSP1 interacts with and degrades human STAT2 through an autophagy pathway, with species-dependent effects. This degradation directly inhibits the expression of interferon-stimulated genes (ISGs). Additionally, NSP1-mediated degradation of STAT2 disrupts mitochondrial dynamics, leading to mitophagy and inhibition of mitochondrial biogenesis. This, in turn, suppresses the host’s innate immune response. Interestingly, we found that inhibiting mitophagy using 3-methyladenine and enhancing mitochondrial biogenesis with the PPARγ agonist pioglitazone can reverse NSP1-mediated inhibition of ISGs, suggesting that promoting mitochondrial mass could serve as an effective antiviral strategy. Specifically, the NSP1 methyltransferase domain binds to the key sites of F175/R176 located in the coiled-coil domain of STAT2. Our findings provide valuable insights into the intricate regulatory cross talk between ALSV and the host’s innate immune response, shedding light on the pathogenesis of this emerging segmented flavivirus and offering potential intervention strategies. IMPORTANCE Alongshan virus (ALSV), a segmented flavivirus belonging to the Flaviviridae family, was first identified in individuals who had been bitten by ticks in Northeastern China. ALSV infection is responsible for causing Alongshan fever, a condition characterized by various clinical symptoms, including fever, headache, skin rash, myalgia, arthralgia, depression, and coma. There is an urgent need for effective antiviral therapies. Here, we demonstrate that ALSV is susceptible to IFN-β but has developed mechanisms to counteract the host’s innate immune response. Specifically, the ALSV nonstructural protein NSP1 interacts with STAT2, leading to its degradation via an autophagy pathway that exhibits species-dependent effects. Additionally, NSP1 disrupts mitochondrial dynamics and suppresses mitochondrial biogenesis, resulting in a reduction in mitochondrial mass, which ultimately contributes to the inhibition of the host’s innate immune response. Interestingly, we found that inhibiting mitophagy and promoting mitochondrial biogenesis can reverse NSP1-mediated suppression of innate immune response by increasing mitochondrial mass. These findings provide valuable insights into the molecular mechanisms of ALSV pathogenesis and suggest potential therapeutic targets against ALSV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Tre…
- College of Wildlife and Protected Area, Northeast Forestry University, Harbin, China.
- School of Pharmaceutical Sciences, Jilin University, Changchun, China.
- Department of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
- College of Veterinary Medicine, Southwest University, Chongqing, China.
- Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
ORCID-Profile: Yinghua Zhao, Jixue Zhao, Yicheng Zhao, Quan Liu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Medical Innovaton Team Project of Jilin University
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (SKL-DTID)
- Wellcome Trust
Zitieren
APA
Zhao, Y., Sui, L., Pan, M., Jin, F., Huang, Y., Fang, S., Wang, M., Che, L., Xu, W., Liu, N., Gao, H., Hou, Z., Du, F., Wei, Z., Bell-Sakyi, L., Zhao, J., Zhang, K., Zhao, Y., & Liu, Q. (2025). The segmented flavivirus Alongshan virus reduces mitochondrial mass by degrading STAT2 to suppress the innate immune response. Journal of Virology, 99(1). https://doi.org/10.1128/jvi.01301-24
Vancouver
Zhao Y, Sui L, Pan M, Jin F, Huang Y, Fang S, et al. The segmented flavivirus Alongshan virus reduces mitochondrial mass by degrading STAT2 to suppress the innate immune response. Journal of Virology. 2025;99(1). doi:10.1128/jvi.01301-24
BibTeX
@article{Zhao2025,
author = {Zhao, Yinghua and Sui, Liyan and Pan, Mingming and Jin, Fangyu and Huang, Yuan and Fang, Shu and Wang, Mengmeng and Che, Lihe and Xu, Wenbo and Liu, Nan and Gao, Haicheng and Hou, Zhijun and Du, Fang and Wei, Zhengkai and Bell-Sakyi, Lesley and Zhao, Jixue and Zhang, Kaiyu and Zhao, Yicheng and Liu, Quan},
title = {The segmented flavivirus Alongshan virus reduces mitochondrial mass by degrading STAT2 to suppress the innate immune response},
journal = {Journal of Virology},
year = {2025},
volume = {99},
number = {1},
doi = {10.1128/jvi.01301-24}
}
EUVIMED